venous flow Articles
-
Amplifi Vein Dilation System: A novel device under development designed to prepare veins for AVF creation
The Amplifi Vein Dilation System (Artio Medical) is is an innovative device designed to dilate arm veins in preparation for AVF surgery using rapid, non-pulsatile venous blood flow. Surendra Shenoy, M.D. (a vascular surgeon with specialist interest in vascular access and transplantation at Washington University School of Medicine, St Louis, Missouri, USA) describes the system as one of the most ...
-
Philips to further expand its image-guided therapy devices portfolio through acquisition of Vesper Medical
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices ...
-
Academic research conclusion: Is exercising inside hyperbaric chamber the next big thing?
The beneficial effects of hyperoxia supplementation on oxygen transport system capacity, lactic acid metabolism capacity, power output performance, and endurance exercise tolerance have been described in multiple previous studies (Sperlich et al., 2017; Cardinale and Ekblom, 2018). With regard to exercise performance, Knight et al. (1993) used a combination of femoral arterial and venous ...
-
LimFlow Percutaneous Deep Venous Arterialization
What interested you in LimFlow, and how did you get involved in the PROMISE I trial? Dr. Clair: Practicing vascular surgery, where a number of patients are evaluated for chronic limb-threatening ischemia (CLTI), you are guaranteed to have patients who are not candidates for percutaneous or surgical revascularization. These patients often have arterial systems open or identifiable to the ankle, ...
-
The Evolving Role of Percutaneous Deep Venous Arterialization
The increasing incidence of peripheral artery disease (PAD) is occurring globally as populations age and rates of diabetes, obesity, and renal disease increase.1-3 Although most of these patients have no symptoms, when the disease progresses to its most advanced form, chronic limb-threatening ischemia (CLTI), there is a significant risk for limb loss. Despite the fact that our revascularization ...
-
Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure
Abstract Acute decompensated heart failure remains the most common cause of hospitalization in older adults, and studies of pharmacological therapies have yielded limited progress in improving outcomes for these patients. This has prompted the development of novel device–based interventions, classified mechanistically based on the way in which they intend to improve central hemodynamics, ...
-
Cost-Effectiveness of Percutaneous Deep Vein Arterialization for Patients with No-Option Chronic Limb-Threatening Ischemia: an Exploratory Analysis Based on the PROMISE I Study
Abstract Background. As the most advanced stage of peripheral arterial disease (PAD), chronic limb-threatening ischemia (CLTI) is associated with a high risk of lower-limb loss and mortality. Percutaneous deep vein arterialization (pDVA) is a promising new treatment alternative for CLTI patients who cannot be treated with conventional revascularization techniques. Our study objective was to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you